Send to a Friend Font Size: Increase Decrease

EXEL and NTRA Related Headlines

Jan 7, 2026 08:02AM Exelixis and Natera partner on phase 3 colorectal cancer trial
Jan 7, 2026 08:00AM Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer

EXEL and NTRA Related Press Releases

Jan 7, 2026 08:00AM Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer

EXEL and NTRA Related SEC Filings